Last updated 16 days ago

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

1590 patients around the world
Available in United States, Spain
Janssen Research & Development, LLC
8Research sites
1590Patients around the world
This study is for people with
Multiple myeloma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Hospital Universitario Virgen de las Nieves
Recruiting
Av. de las Fuerzas Armadas, 2, 18014 Granada
Hospital Universitario 12 de Octubre
Recruiting
Av. de Córdoba, s/n, 28041 Madrid
Hospital Universitario La Paz
Recruiting
Madrid, 28046
Hospital HM Sanchinarro
Recruiting
Calle Oña, 10 28050 Madrid
Hospital Clínico Universitario de Salamanca
Recruiting
Paseo de San Vicente, 182, 37007 Salamanca, España
Hospital Universitari MútuaTerrassa
Recruiting
Plaça del Doctor Robert, 5, 08221 Terrassa, Barcelona
Hospital Clínico Universitario de Valencia
Recruiting
Av. de Blasco Ibáñez, 17, 46010 València, Valencia
Hospital Universitari Son Espases
Recruiting
Carretera de Valldemossa, 79, 07120 Palma, Illes Balears
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy